We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 52.03%
This Fund
S&P 500
This Quarter Est. Return
-18.69%
1 Year Est. Return
+52.03%
3 Year Est. Return
+131.18%
5 Year Est. Return
+187.67%
10 Year Est. Return
+1,140.82%
AUM
$714M
AUM Growth
-$199M
Cap. Flow
+$8.81M
Cap. Flow %
1.23%
Top 10 Hldgs %
30.92%
Holding
97
New
3
Increased
39
Reduced
32
Closed
12

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$10.8M
2
ABBV icon
AbbVie
ABBV
+$10.2M
3
CVS icon
CVS Health
CVS
+$8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.61M
5
UNH icon
UnitedHealth
UNH
+$6.05M

Top Sells

Rank Stock Value
1
DERM
Dermira, Inc.
DERM
+$12.1M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$10.1M
4
HUM icon
Humana
HUM
+$7.42M
5
BDX icon
Becton Dickinson
BDX
+$5.06M

Sector Composition

Rank Sector Weight
1 Healthcare 99.86%
2 Energy 0.06%
3 Technology 0.03%
4 Financials 0.02%
5 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABEO icon
76
Abeona Therapeutics
ABEO
$309M
$2M 0.28%
38,000
-2,000
-5% -$134K
SAGE
77
DELISTED
Sage Therapeutics
SAGE
$1.44M 0.2%
50,000
– –
CLLS
78
Cellectis
CLLS
$148M
$1.33M 0.19%
144,604
– –
VKTX icon
79
Viking Therapeutics
VKTX
$4.15B
$936K 0.13%
200,000
– –
PVLA
80
Palvella Therapeutics
PVLA
$1.99B
$684K 0.1%
3,750
– –
IBM icon
81
IBM
IBM
$212B
$246K 0.03%
2,317
– –
CVX icon
82
Chevron
CVX
$401B
$215K 0.03%
2,974
– –
XOM icon
83
ExxonMobil
XOM
$660B
$205K 0.03%
5,388
+1,534
+40% +$84.7K
JHG
84
DELISTED
Janus Henderson
JHG
$163K 0.02%
10,645
– –
F icon
85
Ford
F
$50.7B
$141K 0.02%
29,164
– –
BUD icon
86
AB InBev
BUD
$154B
– –
-2,806
Closed -$230K
DIS icon
87
Walt Disney
DIS
$183B
– –
-2,083
Closed -$301K
GEN icon
88
Gen Digital
GEN
$12.9B
– –
-8,761
Closed -$224K
GOOGL icon
89
Alphabet (Google) Class A
GOOGL
$4.21T
– –
-3,200
Closed -$214K
HAL icon
90
Halliburton
HAL
$27.3B
– –
-8,299
Closed -$203K
JPM icon
91
JPMorgan Chase
JPM
$912B
– –
-2,095
Closed -$292K
QCOM icon
92
Qualcomm
QCOM
$216B
– –
-3,391
Closed -$299K
REGN icon
93
Regeneron Pharmaceuticals
REGN
$81.1B
– –
-27,000
Closed -$10.1M
RGNX icon
94
Regenxbio
RGNX
$488M
– –
-75,000
Closed -$3.07M
WFC icon
95
Wells Fargo
WFC
$251B
– –
-5,272
Closed -$284K
NSTG
96
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-140,000
Closed -$3.9M
DERM
97
DELISTED
Dermira, Inc.
DERM
– –
-800,000
Closed -$12.1M
1 2 3
4

Similar funds

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
PCI
Planning Center Inc Moline, Illinois $1.06B AUM 12.82% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
BDP
Brehaut David Pascal $1.06B AUM
GX
Greylock XIV Menlo Park, California $1.06B AUM
CIC
Cutler Investment Counsel Jacksonville, Oregon $1.06B AUM 20.29% 1-Year Est. Return
RCIM
Red Cedar Investment Management Grand Rapids, Michigan $1.06B AUM 30.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Rhenman & Partners Asset Management held 97 positions worth $714M, down 22% from $913M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rhenman & Partners Asset Management's Q1 2020 filing shows 3 new, 39 increased, 32 reduced and 12 closed positions. Its largest new stake was Zimmer Biomet: 82,400 shares worth $8.09M. The largest sale was Dermira, Inc., an estimated $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Energy and Technology.

  • Rhenman & Partners Asset Management's largest Q1 2020 buy was Zimmer Biomet: 82,400 shares worth $8.09M.
  • Rhenman & Partners Asset Management added most to AbbVie in Q1 2020, an estimated $10.2M increase.
  • Rhenman & Partners Asset Management's biggest Q1 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $10.3M.
  • Rhenman & Partners Asset Management fully exited Dermira, Inc. in Q1 2020, selling an estimated $12.1M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 31% of its $714M portfolio in Q1 2020.
  • Rhenman & Partners Asset Management opened 3 new positions and closed 12 in Q1 2020.
  • Rhenman & Partners Asset Management's portfolio value fell 22% quarter-over-quarter to $714M.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2020, filed 16 Apr 2020.